SKI Market

Indian Indices

Nifty

22,397.20 -73.30
(-0.33%)

Sensex

73,828.91 -200.85
( -0.27%)

Bank Nifty

48,060.40 3.75
( 0.01%)

Nifty IT

36,122.50 -188.15
( -0.52%)

Global Indices

Nasdaq

41,509.19 674.61
(1.65%)

Dow Jones

5,640.75 101.25
(1.83%)

Hang Seng

37,101.64 311.61
(0.85%)

Nikkei 225

8,639.65 97.09
(1.14%)

Forex

USD-INR

87.03 -0.19
(-0.21%)

EUR-INR

94.57 -0.49
(-0.52%)

GBP-INR

112.71 -0.20
(-0.18%)

JPY-INR

0.59 0.00
(0.06%)

YOU ARE HERE :
HOME
Markets
Equity
Profit and Loss

EQUITY - MARKET SCREENER

Bacil Pharma Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs

BSE Code

ISIN Demat

Book Value()

524516

INE711D01018

1.7864177

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

N.A

62.02

21.55

EPS(TTM)

Face Value()

Div & Yield %

0.59

Particulars(INCOME)	Mar 2024 ( Cr)	Mar 2023 ( Cr)	Mar 2022 ( Cr)	Mar 2021 ( Cr)	Mar 2020 ( Cr)	Mar 2019 ( Cr)
Sales Turnover	0.00	0.00	0.00	0.00	0.00	0.00
Excise Duty	0.00	0.00	0.00	0.00	0.00	0.00
Net Sales	0.00	0.00	0.00	0.00	0.00	0.00
Other Income	0.13	0.11	0.06	0.07	0.14	0.09
Stock Adjustments	0.00	0.00	0.00	0.00	0.00	0.00
Total Income	0.13	0.11	0.06	0.07	0.14	0.09
EXPENDITURE :
Raw Materials	0.00	0.00	0.00	0.00	0.00	0.00
Power & Fuel Cost	0.00	0.00	0.00	0.00	0.00	0.01
Employee Cost	0.10	0.09	0.06	0.05	0.09	0.08
Other Manufacturing Expenses	0.00	0.00	0.00	0.00	0.00	0.01
Selling & Administrative Expenses	0.08	0.08	0.09	0.08	0.08	0.16
Miscellaneous Expenses	0.00	0.05	3.76	0.17	0.26	0.18
Less : Pre-operative Expenses Capitalised	0.00	0.00	0.00	0.00	0.00	0.00
Total Expenditure	0.19	0.21	3.91	0.30	0.44	0.43
Operating Profit	-0.06	-0.10	-3.86	-0.23	-0.30	-0.33
Interest	0.00	0.00	0.00	0.00	0.01	0.00
Gross Profit	-0.06	-0.10	-3.86	-0.23	-0.31	-0.33
Depreciation	0.00	0.00	0.00	0.00	0.01	0.01
Profit Before Tax	-0.06	-0.10	-3.86	-0.23	-0.32	-0.34
Tax	0.00	0.00	0.00	0.00	0.00	0.00
Fringe Benefit tax	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax	0.00	0.00	0.00	0.00	0.00	0.00
Reported Net Profit	-0.06	-0.10	-3.86	-0.24	-0.32	-0.34
Extraordinary Items	0.10	0.05	-3.76	-0.14	-0.26	-0.16
Adjusted Net Profit	-0.16	-0.15	-0.10	-0.10	-0.06	-0.18
Adjustment below Net Profit	0.17	-0.02	3.69	0.24	-0.21	0.02
P & L Balance brought forward	-5.43	-5.30	-5.14	-5.14	-4.62	-4.29
Statutory Appropriations	0.00	0.00	0.00	0.00	0.00	0.00
Appropriations	0.00	0.00	0.00	0.00	0.00	0.00
P & L Balance carried down	-5.31	-5.43	-5.30	-5.14	-5.14	-4.62
Dividend	0.00	0.00	0.00	0.00	0.00	0.00
Preference Dividend	0.00	0.00	0.00	0.00	0.00	0.00
Equity Dividend %	0.00	0.00	0.00	0.00	0.00	0.00
Dividend Per Share(Rs)	0.00	0.00	0.00	0.00	0.00	0.00
Earnings Per Share-Unit Curr	-0.09	-0.16	-5.91	-0.37	-0.48	0.00
Earnings Per Share(Adj)-Unit Curr	-0.09	-0.16	-5.91	-0.37	-0.48	0.00
Book Value-Unit Curr	1.86	1.68	1.88	2.13	2.12	2.93
Book Value(Adj)-Unit Curr	1.86	1.68	1.88	2.13	2.12	2.93

22,397.20 -73.30 (-0.33%)

73,828.91 -200.85 ( -0.27%)

48,060.40 3.75 ( 0.01%)

36,122.50 -188.15 ( -0.52%)

41,509.19 674.61 (1.65%)

5,640.75 101.25 (1.83%)

37,101.64 311.61 (0.85%)

8,639.65 97.09 (1.14%)

87.03 -0.19 (-0.21%)

94.57 -0.49 (-0.52%)

112.71 -0.20 (-0.18%)

0.59 0.00 (0.06%)